Low-grade serous ovarian carcinoma (LGSOC) is a distinct pathologic and clinical entity,
characterized by less aggressive biological behavior, lower sensitivity to chemotherapy and …

Ovarian low-grade serous ovarian carcinoma (OvLGSCa) comprises a minority within the
heterogeneous group of ovarian carcinomas. Despite biological differences with their high …

High-grade serous ovarian cancers (HGSOCs) most commonly arise from the fimbrial end of
the fallopian tube and harbor TP53 gene mutations. In contrast, low-grade serous ovarian …

Low-grade serous ovarian cancer (LGSC) is a morphologically and molecularly distinct
subtype of ovarian cancer, accounting for~ 10% of serous carcinomas. Women typically …

In the early 2000s a two-tier grading system was introduced for serous ovarian cancer. Since
then, we have increasingly come to accept that low-grade serous ovarian carcinoma …

Simple summary Low-grade serous ovarian cancer (LGSOC) represents an uncommon
histotype of serous ovarian cancer (accounting for approximately 5% of all ovarian cancer) …

Background Data on platinum sensitivity of low‐grade serous ovarian carcinoma (LGSOC)
in the upfront setting is lacking, and there is limited and contradictory information on …

Low-grade serous carcinoma (LGSC) of the ovary is a rare histological subtype of epithelial
ovarian carcinoma. It has distinct clinical behavior and a specific molecular profile …

Objectives Women with advanced-stage, low-grade serous ovarian carcinoma (LGSC) have
low chemotherapy response rates and poor overall survival. Most LGSC tumors overexpress …

Compared with high-grade serous carcinoma, low-grade serous carcinoma of the ovary or
peritoneum is a less frequent epithelial ovarian cancer type that is poorly sensitive to …